Ph. Voermans et al., INDUCTION OF ANNEXIN-1 AT TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL LEVEL IN RAT-BRAIN BY METHYLPREDNISOLONE AND THE 21-AMINOSTEROID U74389F, Mediators of inflammation, 5(5), 1996, pp. 370-378
BRAIN tissue of rats pretreated with methylprednisolone or with the 21
-aminosteroid U74389F, and that of untreated control rats, was assesse
d for the expression of annexin-l (Anx-1) and the transcription of its
mRNA. For this purpose Anx-1 cDNA was amplified and simultaneously a
T7-RNA-polymerase promoter was incorporated into the cDNA using a poly
merase chain reaction (PCR). Then digoxigenin-11-UTP was incorporated
into the transcribed cRNA with T7-RNA-polymerase. With this probe ill
situ hybridization was carried out on sections of the brain. The probe
was visualized by an immunoassay using an anti-digoxigenin antibody c
onjugate. Anx-1 protein was assessed by means of immunohistochemistry
using a polyclonal antibody. The various brain areas of the control an
imals showed an appreciable amount of Anx-1 at mRNA or protein level;
on the other hand, the animals which had been pretreated with either s
teroid, showed a more intense Anx-1 mRNA signal than the controls in m
any areas. In the pretreated animals Anx-1 immunostaining was unchange
d in cortex, basal ganglia, amygdala and septum, but more intense in h
ippocampus, hypothalamus and thalamus. In ependyma, choroid plexus, me
ninges, and vascular walls there was no Anx-1 mRNA transcription detec
table. An opposite profile was shown by the Anx-1 immunoreactivity, th
e protein was present in control animals as well as the steroid-pretre
ated animals, suggesting that here the protein was either from systemi
c origin, or has diffused from adjacent structures. The results indica
ted that Anx-1 mRNA transcription is upregulated by either steroid, an
d that in the untreated animals there is a resting level of Anx-1 mRNA
transcription, presumably reflecting physiological influences on Anx-
1 expression.